[go: up one dir, main page]

DZ1779A1 - Process for the preparation of dry prepared particles thus obtained and pharmaceutical compositions containing such particles. - Google Patents

Process for the preparation of dry prepared particles thus obtained and pharmaceutical compositions containing such particles.

Info

Publication number
DZ1779A1
DZ1779A1 DZ940045A DZ940045A DZ1779A1 DZ 1779 A1 DZ1779 A1 DZ 1779A1 DZ 940045 A DZ940045 A DZ 940045A DZ 940045 A DZ940045 A DZ 940045A DZ 1779 A1 DZ1779 A1 DZ 1779A1
Authority
DZ
Algeria
Prior art keywords
particles
preparation
pharmaceutical compositions
compositions containing
dry prepared
Prior art date
Application number
DZ940045A
Other languages
French (fr)
Inventor
Jean-Marc Ruiz
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Application granted granted Critical
Publication of DZ1779A1 publication Critical patent/DZ1779A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DZ940045A 1993-05-15 1994-05-15 Process for the preparation of dry prepared particles thus obtained and pharmaceutical compositions containing such particles. DZ1779A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same

Publications (1)

Publication Number Publication Date
DZ1779A1 true DZ1779A1 (en) 2002-02-17

Family

ID=10735537

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ940045A DZ1779A1 (en) 1993-05-15 1994-05-15 Process for the preparation of dry prepared particles thus obtained and pharmaceutical compositions containing such particles.

Country Status (34)

Country Link
JP (1) JP3139913B2 (en)
KR (1) KR100341261B1 (en)
CN (1) CN1050534C (en)
AT (1) AT406017B (en)
AU (1) AU685094B2 (en)
BE (1) BE1008323A3 (en)
BR (1) BR9401968A (en)
CA (1) CA2123481C (en)
CH (1) CH688572A5 (en)
DE (1) DE4416812C2 (en)
DK (1) DK171454B1 (en)
DZ (1) DZ1779A1 (en)
ES (1) ES2097083B1 (en)
FI (1) FI112915B (en)
FR (1) FR2705232B1 (en)
GB (2) GB9310030D0 (en)
GR (1) GR1002034B (en)
HU (1) HU220617B1 (en)
IE (1) IE940392A1 (en)
IN (1) IN182330B (en)
IT (1) IT1269508B (en)
LU (1) LU88482A1 (en)
MA (1) MA23194A1 (en)
NL (1) NL9400795A (en)
NO (1) NO307403B1 (en)
NZ (1) NZ260520A (en)
OA (1) OA09939A (en)
PL (1) PL175780B1 (en)
PT (1) PT101518B (en)
RU (1) RU2125869C1 (en)
SE (1) SE519004C2 (en)
SG (1) SG46631A1 (en)
TN (1) TNSN94046A1 (en)
ZA (1) ZA943316B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1203591B1 (en) * 1993-01-06 2007-12-19 Ipsen Manufacturing Ireland Limited biodegradable polyesters for forming ionic molecular conjugates with bioactive polypeptides
RU2185393C2 (en) * 1993-01-06 2002-07-20 Кинертон Лимитед Polyester and polyester-base conjugate
DE19604744A1 (en) 1996-02-09 1997-08-14 Henkel Kgaa Technical di- / triglyceride mixtures
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DE19617137C1 (en) * 1996-04-29 1997-02-27 Henkel Kgaa Use of branched alcohol ester(s) of olefin-di:carboxylic acid copolymers
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
DK1183014T3 (en) * 1999-06-14 2004-02-09 Cosmo Spa Flavored controlled release oral pharmaceutical compositions
CA2427938C (en) 1999-11-15 2010-02-16 Bio Syntech Canada Inc. Novel temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution, composition and preparation thereof
GB2374072B (en) * 2000-06-16 2004-09-22 Nippon Catalytic Chem Ind Crosslinked polymer method for manufacturing it and use thereof
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH468192A (en) * 1964-06-19 1969-02-15 Ciba Geigy Process for the manufacture of medicaments in pearl form
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH672887A5 (en) * 1987-10-14 1990-01-15 Debiopharm Sa
WO1989003678A1 (en) * 1987-10-30 1989-05-05 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
DE3916020C2 (en) * 1989-05-17 1994-06-01 Burkhard Dr Wichert Retarding microparticles made from biodegradable polyesters; Process for their preparation without the use of toxic solvents and pharmaceutical preparations containing these microparticles
DK0452145T3 (en) * 1990-04-12 1996-12-02 Shionogi & Co Coated preparation and preparation thereof
JP3116311B2 (en) * 1990-06-13 2000-12-11 エーザイ株式会社 Manufacturing method of microsphere
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
SE9003296L (en) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab PROCEDURE SHOULD FORMULATE MEDICINAL PRODUCTS
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
SE9101603L (en) * 1991-05-27 1992-09-21 Bengt Hjalmar Aagerup Med Firm METHOD FOR MAKING REPRODUCABLE PARTICLES OF DEFINED SIZE
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
ATE154240T1 (en) * 1992-03-12 1997-06-15 Alkermes Inc ACTH CONTAINING MICRO SPHERES WITH CONTROLLED RELEASE
SE9200858L (en) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Method for producing delayed release pellets
CA2136434C (en) * 1992-06-11 2008-12-02 Howard Bernstein Erythropoietin drug delivery system
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
JP2651320B2 (en) * 1992-07-16 1997-09-10 田辺製薬株式会社 Method for producing sustained-release microsphere preparation
FR2693905B1 (en) * 1992-07-27 1994-09-02 Rhone Merieux Process for the preparation of microspheres for the sustained release of the hormone LHRH and its analogs, microspheres and formulations obtained.
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix

Also Published As

Publication number Publication date
CH688572A5 (en) 1997-11-28
NL9400795A (en) 1994-12-01
ATA98794A (en) 1999-06-15
FI942222L (en) 1994-11-16
HU9401412D0 (en) 1994-08-29
PT101518B (en) 2000-12-29
AU685094B2 (en) 1998-01-15
CA2123481C (en) 2005-01-11
AT406017B (en) 2000-01-25
NZ260520A (en) 1994-12-22
BE1008323A3 (en) 1996-04-02
MA23194A1 (en) 1994-12-31
SE9401557L (en) 1994-11-16
DE4416812A1 (en) 1994-11-17
FR2705232A1 (en) 1994-11-25
IT1269508B (en) 1997-04-01
IN182330B (en) 1999-03-20
ES2097083A1 (en) 1997-03-16
CA2123481A1 (en) 1994-11-16
JP3139913B2 (en) 2001-03-05
GB2277915B (en) 1997-10-29
NO941810D0 (en) 1994-05-13
SE9401557D0 (en) 1994-05-05
TNSN94046A1 (en) 1995-04-25
PL175780B1 (en) 1999-02-26
AU6308494A (en) 1994-11-17
GR1002034B (en) 1995-10-31
IE940392A1 (en) 1994-11-16
ITMI940931A0 (en) 1994-05-11
NO307403B1 (en) 2000-04-03
BR9401968A (en) 1994-12-13
ITMI940931A1 (en) 1995-11-11
FI942222A0 (en) 1994-05-13
RU2125869C1 (en) 1999-02-10
FR2705232B1 (en) 1995-08-25
GB9409565D0 (en) 1994-07-06
HK1002831A1 (en) 1998-09-18
CN1104557A (en) 1995-07-05
GB9310030D0 (en) 1993-06-30
HUT67599A (en) 1995-04-28
DK171454B1 (en) 1996-11-04
HU220617B1 (en) 2002-03-28
DK54994A (en) 1994-11-16
CN1050534C (en) 2000-03-22
LU88482A1 (en) 1994-12-01
DE4416812C2 (en) 2003-02-06
JPH072652A (en) 1995-01-06
SG46631A1 (en) 1998-02-20
OA09939A (en) 1994-11-15
ES2097083B1 (en) 1997-12-01
PT101518A (en) 1995-03-01
SE519004C2 (en) 2002-12-17
KR100341261B1 (en) 2002-09-27
GB2277915A (en) 1994-11-16
ZA943316B (en) 1995-01-16
NO941810L (en) 1994-11-16
FI112915B (en) 2004-02-13

Similar Documents

Publication Publication Date Title
FR2504408B1 (en) PROCESS FOR THE PREPARATION OF SUBMICROSCOPIC PARTICLES, PARTICLES THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DZ2186A1 (en) Mixed pharmaceutical compositions for the treatment of osteoporosis and process for their preparation.
FR2722984B1 (en) PROCESS FOR THE PREPARATION OF DRY PHARMACEUTICAL FORMS AND THE PHARMACEUTICAL COMPOSITIONS THUS PRODUCED
DZ2666A1 (en) Hydroxamic acid derivatives pharmaceutical compositions containing them and process for their preparation.
DZ2595A1 (en) Combinations of pharmaceutical compositions of atorvastatin and antihypertensive agents and process for their preparation.
FR2442054A1 (en) PURIFIED PROTEINS, IN PARTICULAR INTERFERON, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA23632A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA23834A1 (en) PROCESS FOR THE PREPARATION OF INHIBITOR COMPOUNDS OF THE LP-PLA2 ENZYME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
OA07124A (en) Substituted dipipeptides, processes for their preparation and pharmaceutical compositions containing them and their use for the inhibition of encephalinase.
DZ2745A1 (en) Novel bicycloÄ2.2.1Üheptanes for their preparation and pharmaceutical compositions containing them.
DZ2300A1 (en) Substituted 6,5-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2299A1 (en) Substituted 6,6-heterobicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2600A1 (en) Pharmaceutical combinations of amlodipine and estatin and process for their preparation.
TNSN96104A1 (en) (1S, 2S) -1- (4-HYDROXYPHENYL) -2- (4-HYDROXY-4-PHENYLPIPERIDINE-1-YL) -1-PROPANOL TRIHYDRATE METAHENSULFONATE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
FR2627385B3 (en) COMPOSITION ESPECIALLY USEFUL AS A BASE MATERIAL FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS, ESPECIALLY DERMATOLOGICAL AND / OR COSMETIC
DZ2414A1 (en) 2-amino-6- (2-substituted-4-phenoxy) substituted-pyridines process for their preparation and pharmaceutical compositions containing them.
DZ2550A1 (en) Azetidinylpropylpiperidine derivatives process for their preparation and pharmaceutical compositions containing them.
OA09441A (en) "Processes for the preparation of pteridin-4 (3H) -ones, and drug compositions containing them".
DZ1779A1 (en) Process for the preparation of dry prepared particles thus obtained and pharmaceutical compositions containing such particles.
FR2628973B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN USE, AND PROCESS FOR THE PREPARATION OF SUCH A COMPOSITION
FR2642329B1 (en) USE OF ATELOCOLLAGEN AND GLYCOSAMINOGLYCAN SOLUTIONS FOR THE MANUFACTURE OF MICROCAPSULES, MICROCAPSULES MADE THEREOF, METHODS OF MANUFACTURING SUCH MICROCAPSULES AND COSMETIC OR PHARMACEUTICAL OR FOOD COMPOSITIONS CONTAINING THE SAME
PT77452B (en) PROCESS FOR THE PREPARATION OF A NEW GALENIC FORM OF SULPI-RIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PT84184A (en) PROCESS FOR THE PREPARATION OF 8 ALPHA-ACYLAMINOERGOLINES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA24214A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS AND FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2701847B1 (en) Pharmaceutical and cosmetic compositions based on vegetable albumin, preparations containing such compositions and process for their preparation.